Adrenoleukodystrophy Treatment Market: Know Latest Trends & Forecast for Long-Term Business Planning Up to 2030

Wilmington, Delaware, United States, Transparency Market Research Inc. - A rare genetic condition that causes the buildup of long chain fatty acids (VLCFAs) in the brain is known as adrenoleukodystrophy (ALD). A mutation in the ABCD1 gene on the X chromosome leads to ALD. Childhood cerebral ALD, Adrenomyelopathy, and Addison’s disease are the three types of adrenoleukodystrophy. Childhood cerebral ALD progresses very rapidly in children between the ages of 3 and 10 and causes severe disability and even death. Addison’s disease is caused when the adrenal glands are unable to produce enough hormones. It is also known as adrenal insufficiency. Adrenomyelopathy primarily affects adult men.

Access Full Report @ 

Key Drivers, Restrains and Opportunities of Global Adrenoleukodystrophy Treatment Market

Rising awareness about rare diseases leads to increase in potential in research treatment. Moreover, rise in support and funds for research into new ALD treatments contribute to drive the market.

 Surge in number of patient is likely augment the market. For instance, the prevalence of adrenoleukodystrophy, globally, is 1 in 20,000 to 50,000 individuals as per the U.S. National Library of Medicine. 1 in every 21,000 men and 1 in 16,800 women thought to be affected by ALD in the U.S.

Key industry players are engaged in the development of new products by investment in research & developing owing to a rise in the demand for products. This, in turn, is estimated to drive the market. For instance, Viking Therapeutics conducts a clinical trial program for novel VK0214. In September 2020, Viking Therapeutics launched phase I clinical trial testing with increasing doses of VK0214 to treat adrenoleukodystrophy (ALD). In July 2018, NeuroVia, Inc. initiated the Phase 1/2 clinical study of NV1205, in patients with childhood cerebral adrenoleukodystrophy (CCALD).

Request Brochure of Report @ 

However side-effects associated with stem cell therapy and corticosteroid replacement therapy is expected to hamper the market

Government initiatives in developing countries to improve healthcare infrastructure leads to an increase the patient access and thereby offers significant opportunity in the market. Moreover, investment by key players to address the unmet medical needs is providing considerable opportunity in the market

North America to Capture Major Share of Global Adrenoleukodystrophy Treatment Market

North America is expected to account for a major share of the global adrenoleukodystrophy treatment market. It is expected to maintain its dominance during the forecast period. Well-established healthcare infrastructure and presence of key market players are major factors that are anticipated to drive the market.

The adrenoleukodystrophy treatment market in Asia Pacific is estimated to hold significant share of the market. The market in Asia Pacific is projected to expand at a rapid pace during the forecast period owing to a rise in awareness about rare diseases.

Request For Custom Research @ 

Key Players Operating in Global Adrenoleukodystrophy Treatment Market

The global adrenoleukodystrophy market is highly concentrated due to the presence of key players. A large number of manufacturers hold major share in their respective regions. Demand for adrenoleukodystrophy treatment products has increased in emerging as well as developed markets owing to a rise in prevalence of adrenoleukodystrophy. Growth strategies adopted by leading players are likely to drive the global market.

Major players operating in the global adrenoleukodystrophy treatment market are:

  • Minoryx
  • agtc (Applied Genetic Technologies Corporation)
  • Viking Therapeutics, Inc
  • bluebird bio, Inc.
  • SwanBio Therapeutics, Inc.
  • MedDay Pharmaceuticals
  • NeuroVia, Inc

Global Adrenoleukodystrophy Treatment Market: Research Scope

Make an Enquiry before Buying @ 

Global Adrenoleukodystrophy Treatment Market, by Therapy

  • Stem cell transplant
  • Gene therapy
  • Corticosteroid replacement therapy
  • Medications
  • Others

Global Adrenoleukodystrophy Treatment Market, by Types

  • Childhood cerebral ALD
  • Adrenomyelopathy
  • Addison’s disease

More Related Reports by Transparency Market Research – 

Atopic Dermatitis Drugs Market: The global atopic dermatitis drugs market is anticipated to reach more than US$ 29.4 Bn by the end of 2031

Red Biotechnology Market: The global red biotechnology market is anticipated to reach more than US$ 609.6 Bn by the end of 2031

Epilepsy Therapeutics Market: The global epilepsy therapeutics market is anticipated to reach more than US$ 14.9 Bn by the end of 2031

Post-operative Pain Therapeutics Market: The global post-operative pain therapeutics market is anticipated to reach more than US$ 22.3 Bn by the end of 2031

Joint Pain Injections Market: The global joint pain injections market is anticipated to reach more than US$ 9.8 Bn by the end of 2031

Human Microbiome Market: The human microbiome market in India is anticipated to reach more than US$ 282 Mn by the end of 2031

Water for Injection Market: The global water for injection market is anticipated to reach more than US$ 53.8 Bn by the end of 2031

Venous Diseases Treatment Market: The global venous diseases treatment market is anticipated to reach more than US$ 11.3 Bn by 2031

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update -


Rohit Bhisey
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453


Back to news